New Hampshire Oncology - Hematology, PA

Manchester, New Hampshire 03103

0 studies enrolling now · 1 studies all time

What they study most

NSCLC

Studies at this site

• Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC — Running, not enrolling